Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private

BSE1425.450.05 (+0 %)

PREV CLOSE ( ) 1425.40

OPEN PRICE ( ) 1425.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 16990

TODAY'S LOW / HIGH ( )1403.05 1455.00

52 WK LOW / HIGH ( )890 1577.5

NSE1425.20-0.5 (-0.04 %)

PREV CLOSE( ) 1425.70

OPEN PRICE ( ) 1425.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1425.20 (893)

VOLUME 215470

TODAY'S LOW / HIGH( ) 1402.60 1458.00

52 WK LOW / HIGH ( )889 1580

Chairman	Berjis Minoo Desai
Managing Director	Satish Ramanlal Mehta
Company Secretary	Chetan Rajendra Sharma
Non Executive Independent Director	Palamadai Sundararajan Jayakumar Vijay Gokhale Vidya Rajiv Yeravdekar Shailesh Ayyangar
Whole Time Director	Sunil Rajanikant Mehta Namita Vikas Thapar Samit Satish Mehta Mukund Keshao Gurjar

Incorporation Year : 16-04 1981

Registered Office :

Address : Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi Pune,
Maharashtra-411057 .

Phone : 020-3507003 / 35070000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE